Hi @milk Apart from the obvious:
- Some nice commentary on trial results, especially around the contrast between healthy/unhealthy tissue comparisons.
- New research (still ongoing) from Impact Health showing the economic burden/savings in hospitals. See presentation.
- Scott mentioned MRFF is competitive, non dilutive funding would great but also stressed how valuable the collaboration with ASA is from a non-monetary perspective.
- Work on other body applications (torso/chest/skin/wearables) going on in background at UQ but main focus remains on Stroke and the Brain Scanner.
- John, Ron & Scott all seemed very confident and spoke impressively.
Chart, page-1214
-
- There are more pages in this discussion • 1,642 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
0.065(3.27%) |
Mkt cap ! $175.3M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $2.00 | $35.10K | 17.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1206 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.05 | 5674 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |